News: Biologics, Therapeutics and Devices

Here are a handful of ways that members of our science and mathematics community brandished their entrepreneurial spirit this year.

After decades of research, an effective RSV vaccine now seems within reach

A new diagnostic tool can quickly and cheaply identify whether a mosquito belongs to the species that carries dangerous diseases such as Zika virus, dengue...

Cancer research institute CPRIT is supporting bringing new faculty to the college.

Bryan Davies of The University of Texas at Austin and a team have developed a system to identify new options for fighting bacteria.

Scientists borrowed tricks from evolution to develop the world's first treatment for late stage inhalation anthrax.

Cryo-EM allows scientists to see with higher resolution than ever before a host of biological processes and conditions, including DNA repair, cancer and infectious disease.

The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).

Jonathan Sessler of the Department of Chemistry and George Georgiou of the Department of Molecular Biosciences at The University of Texas at Austin have been...